Here, we take advantage of an important genomics resource in AD: ATAC-seq and RNA-seq of activated CD4+ T cells, along with whole-genome sequencing, of AD patients and age-matched controls (Fig 7A) [54]. Here, CD4 is linked to Alzheimer disease.